Cargando…
Iron chelation suppresses secondary bleeding after intracerebral hemorrhage in angiotensin II‐infused mice
AIMS: Secondary bleeding and further hematoma expansion (HE) aggravate brain injury after intracerebral hemorrhage (ICH). The majority of HE results from hypertensive ICH. Previous study reported higher iron content in the brains of hypertensive patients. Iron overload exacerbates the risk of hemorr...
Autores principales: | Wang, Jie, Tang, Xiao‐qin, Xia, Min, Li, Cheng‐cheng, Guo, Chao, Ge, Hong‐fei, Yin, Yi, Wang, Bo, Chen, Wei‐xiang, Feng, Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504530/ https://www.ncbi.nlm.nih.gov/pubmed/34346561 http://dx.doi.org/10.1111/cns.13706 |
Ejemplares similares
-
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang, Chao, et al.
Publicado: (2021) -
The Role of Iron-Chelating Therapy in Improving Neurological Outcome in Patients with Intracerebral Hemorrhage: Evidence-Based Case Report
por: Ramadhan, Mochamad Iskandarsyah Agung, et al.
Publicado: (2023) -
Iron Neurotoxicity and Protection by Deferoxamine in Intracerebral Hemorrhage
por: Li, Zhe, et al.
Publicado: (2022) -
Ferroptosis and Iron Metabolism after Intracerebral Hemorrhage
por: Sun, Yuanyuan, et al.
Publicado: (2022) -
Intracerebral Hemorrhage: Toward Physiological Imaging of Hemorrhage Risk in Acute and Chronic Bleeding
por: Jakubovic, Raphael, et al.
Publicado: (2012)